Evelo Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
Evelo Biosciences, Inc. (EVLO)
Last evelo biosciences, inc. earnings: 2/13 07:00 am
Check Earnings Report
Company Research
Source: GlobeNewswire
—Strong 2019 marked by clinical data that validates platform——Lead inflammation candidate EDP1815 showed positive clinical data across two separate cohorts——EDP1815 Phase 2 study initiation expected in Q2 2020——Multiple clinical readouts across inflammation and oncology portfolio expected throughout 2020——Management to host conference call at 8:30 a.m. EST— CAMBRIDGE, Mass., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today reported financial results and business highlights for the fourth quarter and full year 2019. “2019 was a pivotal year for Evelo. We reported positive clinical data supporting the validation of our novel platform and demonstrating that we can target SINTAX™, the small intestinal axis, to drive clinical effects in individuals with psoriasis. These data support the role of SINTAX as an important new therapeutic targ
Show less
Read more
Impact Snapshot
Event Time:
EVLO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVLO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVLO alerts
High impacting Evelo Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
EVLO
Earnings
- 11/9/23 - Beat
EVLO
Sec Filings
- 3/11/24 - Form EFFECT
- 1/26/24 - Form 15-12G
- 1/26/24 - Form S-8
- EVLO's page on the SEC website